Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4000563 | Urologic Oncology: Seminars and Original Investigations | 2009 | 5 Pages |
Abstract
Patients with svPC and patients with InsigPC have a significantly lower risk of BCR. However, even in this seemingly very favorable patient group, 1 in 10 patients will develop a BCR after RP. Therefore, new studies are needed to examine what the prognostic relevance is of small-volume tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
I.M. M.D., Dieuwertje E.G. M.Sc., Lambertus A. Ph.D., Christina A. M.D., Ph.D., J. Alfred M.D., Ph.D.,